Osimertinib tolerance in a patient with Stevens Johnson syndrome during osimertinib therapy after treatment with pembrolizumab.

Lopez, Michael; Hagopian, Garo; Doan, Linda; Lee, Benjamin J; Rojek, Nathan W; Smith, Janellen; Ou, Sai-Hong Ignatius; Demirdag, Yesim Yilmaz; Nagasaka, Misako

Lopez, Michael; Hagopian, Garo; Doan, Linda; Lee, Benjamin J; Rojek, Nathan W; Smith, Janellen; Ou, Sai-Hong Ignatius; Demirdag, Yesim Yilmaz; Nagasaka, Misako.

Afiliación

Lopez M; Division of Basic and Clinical Immunology, Department of Medicine, University of California, Irvine, USA.
Hagopian G; Division of Hematology and Oncology, Department of Medicine, University of California, Irvine, USA.
Doan L; Department of Dermatology, University of California, Irvine, USA.
Lee BJ; Department of Pharmacology, University of California, Irvine, USA.
Rojek NW; Department of Dermatology, University of California, Irvine, USA.
Smith J; Department of Dermatology, University of California, Irvine, USA.
Ou SI; Division of Hematology and Oncology, Department of Medicine, University of California, Irvine, USA.
Demirdag YY; Division of Basic and Clinical Immunology, Department of Medicine, University of California, Irvine, USA. dryesimyilmaz@gmail.com.
Nagasaka M; Division of Hematology and Oncology, Department of Medicine, University of California, Irvine, USA.

Allergy Asthma Clin Immunol ; 19(1): 93, 2023 Oct 28.

Article en En | MEDLINE | ID: mdl-37898814

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Allergy Asthma Clin Immunol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google